Navigation Links
Sangamo BioSciences Announces First Quarter 2015 Conference Call and Webcast
Date:4/15/2015

RICHMOND, Calif., April 15, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO) today announced that the company will release its first quarter 2015 financial results after the market closes on Wednesday, April 22, 2015. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the quarter's financial results and discuss other business matters.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 20895051.  Participants may access the live webcast via a link on the Sangamo BioSciences website in the Investors section under Events and Presentations. For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8:00 p.m. ET on April 22, 2015 to 11:59 p.m. ET on April 29, 2015. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 20895051.

About Sangamo
Sangamo BioSciences, Inc. is focused on Engineering Genetic CuresTM for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic gene regulation and genome editing. The Company has clinical stage programs to evaluate the safety and efficacy of novel ZFP Therapeutics® for the treatment of HIV/AIDS (SB-728-T), beta-thalassemia (SB-BCLmR-HSPC), and NGF-AAV for Alzheimer's disease (CERE-110). Sangamo's other therapeutic programs are focused on monogenic and rare diseases. The Company has formed a strategic collaboration with Shire International GmbH to develop therapeutics for hemophilia, Huntington's disease and other monogenic diseases, and with Biogen for hemoglobinopathies, such as sickle cell disease and beta-thalassemia. It has also established strategic partnerships with companies in non-therapeutic applications of its technology, including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the Company's website at www.sangamo.com.

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

Logo - http://photos.prnewswire.com/prnh/20130102/SF35903LOGO

 


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative Medicines Advanced Therapies Summit
2. Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014
3. Sangamo BioSciences Announces Target Date For First IND For Sangamos In Vivo ZFN Genome-Editing Platform For Monogenic Diseases
4. Sangamo BioSciences Announces Presentation At ICAAC of New Clinical Data Demonstrating Sustained Functional Control of Viremia in Multiple HIV-Infected Subjects Treated with SB-728-T
5. Five Sangamo Scientists Recognized By Thomson Reuters Among Most Highly Cited Researchers Worldwide Of 2014
6. Sangamo BioSciences to Focus on Advancing ZFP Therapeutic Pipeline at J.P. Morgan Healthcare Conference
7. Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies
8. Sangamo BioSciences Presents Clinical Data From Key SB-728-T HIV Studies: Proof Of Concept For Ongoing Sustained Functional Control Of HIV Viral Load; Cytoxan Preconditioning Successfully Enhances Engraftment
9. Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
10. Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia
11. Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2018)... ... , ... Precision Orthopedics & Sports Medicine announced the addition of ... Fellowship trained in Spine Surgery, Dr. Gengler will practice alongside Dr. Robert Bayless, ... Sandhu, and Dr. Tariq Hendawi beginning September 4, 2018. , Robert E. ...
(Date:8/31/2018)... ... August 31, 2018 , ... Power Systems, a leading provider of ... brand, have partnered in a shared mission to motivate 100 million people to get ... on the rise since 2010, offering competitors a fun and complete physical challenge. Spartan ...
(Date:8/31/2018)... ... 31, 2018 , ... Travel tech specialist Aquarium Software has welcomed news that ... a new service for the disabled. The move is an admission that some consumers ... in the UK living with a disability, Aquarium Software says thoughts now need to ...
Breaking Medicine Technology:
(Date:9/1/2018)... ... 2018 , ... September is Animal Pain Awareness Month, a ... that aims to encourage pain management for all animals through education and advocacy. ... owners of the many forms of pain and the importance of pain management ...
(Date:8/31/2018)... GRAND RAPIDS, Mich. (PRWEB) , ... August 31, ... ... Services treatment provider, will host an Open House on Wednesday, September 12 from ... recovery options available in Grand Rapids, as well as tour the facility, meet ...
(Date:8/31/2018)... ... August 31, 2018 , ... The social impact documentary feature film on homelessness, ... NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has been faring well at ... International Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, and Top Indie ...
(Date:8/31/2018)... , ... August 31, 2018 , ... Nitro Circus hosted ... at the Beach – an action sports gathering to celebrate the life of Erik ... event raised money for Erik’s wife, Annika and their two small children, Oskar (8) ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... of South Jersey Gastroenterology for another year. Dr. Savon has been active in ... the leaders in comprehensive care for all gastrointestinal diseases and disorders for the ...
Breaking Medicine News(10 mins):